We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Search results
From Proteopedia
You searched for Mthfd2
There is no page with the exact title "Mthfd2". The search results for "Mthfd2" are displayed below. You can create a page titled Mthfd2 (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Mthfd2 (37 bytes)
1: List of pages with the keyword Mthfd2
Page text matches
- 9itd (4,463 bytes)
16: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 9iuo (4,445 bytes)
16: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 2eo2 (2,551 bytes)
10: ...ls complementing thus the enzymatic activities of MTHFD2. - 5tc4 (2,344 bytes)
2: ...enetetrahydrofolate dehydrogenase-cyclohydrolase (MTHFD2) in complex with LY345899 and cofactors== - 5o22 (3,372 bytes)
14: ...arolacton as an inhibitor tool compound to assess MTHFD2 as an anti-cancer target. - 5o28 (3,298 bytes)
14: ...arolacton as an inhibitor tool compound to assess MTHFD2 as an anti-cancer target. - 5o2a (3,290 bytes)
14: ...arolacton as an inhibitor tool compound to assess MTHFD2 as an anti-cancer target. - 9ise (4,421 bytes)
16: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 9isl (4,448 bytes)
16: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 9is9 (3,837 bytes)
2: ==human MTHFD2 in complex with LY374571==
14: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 9isc (3,879 bytes)
2: ==Human MTHFD2 in complex with compound 16a==
14: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 9isr (4,475 bytes)
16: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 9it6 (3,892 bytes)
2: ==Human MTHFD2 in complex with compound 16g==
14: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 9ita (3,861 bytes)
2: ==Human MTHFD2 in complex with compound 16d==
14: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 6jib (3,321 bytes)
2: ==Human MTHFD2 in complex with DS44960156==
14: ...: (1) unprecedented selectivity (>18-fold) for MTHFD2 over MTHFD1, (2) a molecular weight of less than ...
16: ...ased Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold.,Kaw... - 6jid (3,393 bytes)
2: ==Human MTHFD2 in complex with Compound 1==
14: ...: (1) unprecedented selectivity (>18-fold) for MTHFD2 over MTHFD1, (2) a molecular weight of less than ...
16: ...ased Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold.,Kaw... - 9it3 (3,864 bytes)
2: ==Human MTHFD2 in complex with compound 16e==
14: ...nstrating superior inhibition and selectivity for MTHFD2, favorable pharmacokinetics, and potent antitumor... - 6s4a (2,815 bytes)
2: ==Structure of human MTHFD2 in complex with TH9028== - 6s4e (2,703 bytes)
2: ==Structure of human MTHFD2 in complex with TH7299== - 6s4f (2,778 bytes)
2: ==Structure of human MTHFD2 in complex with TH9619==
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
